Medicinal cannabis extracts are neuroprotective against Aβ1–42‐mediated toxicity in vitro

Background Phytocannabinoids inhibit the aggregation and neurotoxicity of the neurotoxic Alzheimer's disease protein β amyloid (Aβ). We characterised the capacity of five proprietary medical cannabis extracts, heated and non‐heated, with varying ratios of cannabidiol and Δ9‐tetrahydrocannabinol...

Ausführliche Beschreibung